代谢综合征为心血管疾病的公认危险因素,且将增加其并发症与死亡风险,而代谢综合征常伴有维生素D水平低下。既往发现,适度理想的维生素D水平与一般人群总死亡和心血管病死亡风险降低有关,但其与代谢综合征患者总死亡及心血管病死亡风险间关系尚不清楚,现就适度理想的25-羟化维生素D[25(OH)D]与其之间相关关系进行比较分析。 Metabolic syndrome is a recognized risk factor for cardiovascular disease and will increase its risk of complications and death, while metabolic syndrome is often associated with low vitamin D levels. It has been previously found that a modestly desirable level of vitamin D is associated with a reduction in the overall risk of death and cardiovascular disease in the general population, but the relationship between the level of vitamin D and the risk of total mortality and cardiovascular death in patients with metabolic syndrome remains unclear. - hydroxy vitamin D [25 (OH) D] and its correlation between the comparative analysis.